Rutgers, The State University of New Jersey

Researchers

• AKAnita Y Kinney

Running trials

• Not yet recruiting

  The Study of Brave-LC LDN Treatment Trial

  NCT07916259· Phase 3· National Institute of Allergy and Infectious Diseases (NIAID)· Source

• Enrolling by invitation

  Partial Enteral Nutrition as Therapeutic Augmentation of Advanced Pharmacological Therapy in Patients With Active Crohn's Disease

  NCT07356232· James Lewis· Source

• Not yet recruiting

  Remote Patient Monitoring for Chronic Hypertension During Pregnancy (REACH)

  NCT07115199· Rutgers, The State University of New Jersey· Source

• Recruiting

  INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery

  NCT06965504· Abiomed Inc.· Source

• Recruiting

  Rutgers University Study of the Genetics of Blood Cancers

  NCT07714044· Rutgers, The State University of New Jersey· Source

• Recruiting

  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  NCT07497087· Phase 3· Boehringer Ingelheim· Source

• Enrolling by invitation

  Case-Specific Health Care Professional Clinical Survey for Concerto Versa™ Detachable Coils

  NCT07639853· Medtronic Endovascular· Source

• Recruiting

  A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications

  NCT07330258· Bayer· Source

• Recruiting

  Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer

  NCT07484022· Phase 1· Generate Biomedicines· Source

• Recruiting

  Phase 2 Study to Assess the Safety and Efficacy of ANG003

  NCT07450547· Phase 2· Anagram Therapeutics, Inc.· Source

• Recruiting

  A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation

  NCT07523750· Biosense Webster, Inc.· Source

• Active, not recruiting

  A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, and Pharmacodynamics of P-CD19CD20-ALLO1 in Participants With Multiple Sclerosis

  NCT07008378· Phase 1· Genentech, Inc.· Source

• Recruiting

  Individualizing Treatment for Asthma in Primary Care (Full Study)

  NCT07052942· Phase 4· DARTNet Institute· Source

• Recruiting

  Study With Phage for CF Subjects With Pseudomonas Lung Infection

  NCT06998043· Phase 2· BiomX Ltd· Source

• Recruiting

  The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

  NCT06872892· Phase 3· Boehringer Ingelheim· Source

• Recruiting

  CBT-I in Older African American Adults

  NCT06791356· Rutgers, The State University of New Jersey· Source

• Recruiting

  A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

  NCT06977581· Phase 2· Pfizer· Source

• Recruiting

  Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  NCT06563895· Phase 3· Eidos Therapeutics, a BridgeBio company· Source

• Recruiting

  Non-Invasive Preeclampsia Screening and Biobank

  NCT06643741· Sequenom, Inc.· Source

• Recruiting

  Mechanisms of Uterine Fluid Absorption During Early Pregnancy ( ELF Study)

  NCT06847685· Johns Hopkins University· Source

• Active, not recruiting

  A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine

  NCT06616194· Phase 3· Pfizer· Source

• Active, not recruiting

  ABA-101 in Participants With Progressive Multiple Sclerosis

  NCT06566261· Phase 1· Abata Therapeutics· Source

• Recruiting

  Reducing Urban Cervical Cancer Disparities

  NCT06416150· Fox Chase Cancer Center· Source

• Enrolling by invitation

  HomeStyles-Adults of Chinese Heritage

  NCT06136793· Rutgers, The State University of New Jersey· Source

• Active, not recruiting

  A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis

  NCT06298552· Phase 3· argenx· Source

• Active, not recruiting

  A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)

  NCT06223360· Phase 2· Weill Medical College of Cornell University· Source

• Active, not recruiting

  Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

  NCT06141473· Phase 3· Sanofi· Source

• Recruiting

  uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

  NCT05874921· UroGen Pharma Ltd.· Source

• Active, not recruiting

  The BD Liverty™ TIPS Stent Graft Study

  NCT05711316· C. R. Bard· Source

• Recruiting

  The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

  NCT05836987· Phase 3· Johns Hopkins University· Source

• Recruiting

  Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

  NCT05548283· Phase 4· Chris Goss· Source

• Active, not recruiting

  A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors

  NCT05653882· Phase 1· Asher Biotherapeutics, Inc.· Source

• Recruiting

  ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve

  NCT05172960· Edwards Lifesciences· Source

• Recruiting

  Emergent Multi-Class Imitation Training

  NCT05849376· Rutgers, The State University of New Jersey· Source

• Active, not recruiting

  A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer

  NCT05141721· Phase 2/3· Seattle Project Corporation· Source

• Recruiting

  First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

  NCT05216432· Phase 1· Relay Therapeutics, Inc.· Source

• Recruiting

  PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR

  NCT04889872· Edwards Lifesciences· Source

• Active, not recruiting

  A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme

  NCT04762069· Phase 2· CNS Pharmaceuticals, Inc.· Source

• Recruiting

  Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

  NCT04774159· Phase 3· Population Health Research Institute· Source

• Active, not recruiting

  TRISCEND II Pivotal Trial

  NCT04482062· Edwards Lifesciences· Source

• Recruiting

  Parkinson's Foundation PD GENEration Genetic Registry

  NCT04994015· Parkinson's Foundation· Source

• Active, not recruiting

  A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease

  NCT04671771· W.L.Gore & Associates· Source

• Active, not recruiting

  SELUTION SLR™ 014 In-stent Restenosis

  NCT04280029· M.A. Med Alliance S.A.· Source

• Active, not recruiting

  Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial

  NCT03947619· Abiomed Inc.· Source

• Active, not recruiting

  Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations

  NCT04006210· Phase 3· NeuroDerm Ltd.· Source

• Recruiting

  Stroke Thrombectomy and Aneurysm Registry

  NCT04994756· Medical University of South Carolina· Source

• Active, not recruiting

  Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients

  NCT02922036· EBR Systems, Inc.· Source

• Active, not recruiting

  A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease

  NCT03251118· Target PharmaSolutions, Inc.· Source

• Active, not recruiting

  A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

  NCT02954094· Target PharmaSolutions, Inc.· Source

• Recruiting

  Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

  NCT01574053· CHDI Foundation, Inc.· Source

Showing 50 of 51.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Cystic fibrosis3 recruiting
• Stroke3 recruiting
• Aortic stenosis2 recruiting
• Asthma2 recruiting
• Atrial fibrillation2 recruiting
• Bladder cancer2 recruiting
• High blood pressure2 recruiting
• Peripheral artery disease2 recruiting
• Amyloidosis1 recruiting
• Autism1 recruiting
• Brain aneurysm1 recruiting
• Cervical cancer1 recruiting
• Coronary artery disease1 recruiting
• Crohn's disease1 recruiting
• Heart failure1 recruiting
• Huntington's disease1 recruiting
• Insomnia1 recruiting
• Long COVID and ME/CFS1 recruiting
• Metastatic breast cancer1 recruiting
• Multiple myeloma1 recruiting
• Parkinson disease1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting

Closed trials

• Completed

  Implementation of a Peer Leader-facilitated Dyadic Intervention

  NCT06643806· Rutgers, The State University of New Jersey· Source

• Terminated

  Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy

  NCT06543446· University of Rochester· Source

• Completed

  REVEAL - Research With I-124 EVuzamitide to Elucidate Cardiac AmyLoidosis

  NCT06788535· Phase 3· Sharmila Dorbala· Source

• Completed

  RECOVER-SLEEP: Platform Protocol

  NCT06404086· Phase 2· Duke University· Source

• Completed

  Pharmacokinetics, Pharmacodynamics and Safety of Epeleuton in Patients With Sickle Cell Disease

  NCT05861453· Phase 2· Afimmune· Source

• Completed

  Sistas Informing Sistas on Topics About AIDS and Prevention (SISTA-P)

  NCT06307028· Rutgers, The State University of New Jersey· Source

• Completed

  Choices About Genetic Testing And Learning Your Risk With Smart Technology

  NCT06184867· Rutgers, The State University of New Jersey· Source

• Terminated

  ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal Cancer

  NCT05824559· Phase 1· MEI Pharma, Inc.· Source

• Completed

  RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms

  NCT05595369· Phase 2· Kanecia Obie Zimmerman· Source

• Completed

  HomeStyles-2: Shaping HOME Environments and LifeSTYLES to Prevent Childhood Obesity

  NCT04802291· Rutgers, The State University of New Jersey· Source

• Completed

  Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection

  NCT05616221· Phase 2· Armata Pharmaceuticals, Inc.· Source

• Completed

  Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children

  NCT05634811· Phase 3· Pfizer· Source

• Completed

  Study of DF9001 in Patients With Advanced Solid Tumors

  NCT05597839· Phase 1/2· Dragonfly Therapeutics· Source

• Terminated

  A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)

  NCT05143177· Phase 2/3· REDNVIA Co., Ltd.· Source

• Completed

  Cannabis, HIV and Mental Processing Systems

  NCT05430490· Washington University School of Medicine· Source

• Completed

  A Randomized, Controlled Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System (SUMMIT MAX)

  NCT05018650· Route 92 Medical, Inc.· Source

• Completed

  Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy

  NCT04770337· Neuroelectrics Corporation· Source

• Completed

  A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function

  NCT04038047· Nicole Hamblett· Source

• Completed

  Light, Metabolic Syndrome and Alzheimer's Disease - Aim 2

  NCT03933696· Icahn School of Medicine at Mount Sinai· Source

• Completed

  Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults

  NCT05283967· University of Virginia· Source

• Completed

  Light and the Effect on Metabolic Syndrome and Alzheimer's Disease

  NCT03777722· Icahn School of Medicine at Mount Sinai· Source

• Terminated

  An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection

  NCT03692897· Target PharmaSolutions, Inc.· Source

• Completed

  Studies of Brain and Body Interaction

  NCT03672266· Rutgers University· Source

• Recruiting

  Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction

  NCT02901184· Phase 3· Uppsala University· Source

• Completed

  Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis

  NCT03183245· Phase 3· Humacyte, Inc.· Source

• Completed

  Parkinson Disease and DBS: Cognitive Effects in GBA Mutation Carriers

  NCT03234478· Rutgers, The State University of New Jersey· Source

• Completed

  Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate)

  NCT02844465· MedtronicNeuro· Source

• Completed

  A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)

  NCT02815891· Target PharmaSolutions, Inc.· Source

• Completed

  Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma

  NCT02360579· Phase 2· Iovance Biotherapeutics, Inc.· Source

• Completed

  Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B.

  NCT01467427· Phase 3· Novo Nordisk A/S· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Obesity151 works · 2 trials
• HIV132 works · 2 trials
• Alzheimer disease117 works · 4 trials
• Type 2 diabetes64 works · 2 trials
• Asthma63 works · 2 trials
• Parkinson disease52 works · 5 trials
• Schizophrenia47 works · 0 trials
• Tuberculosis43 works · 1 trial
• Autism36 works · 3 trials
• Bipolar disorder26 works · 0 trials
• Acute myeloid leukaemia23 works · 0 trials
• Spinal cord injury22 works · 0 trials
• Insomnia20 works · 1 trial
• Aortic stenosis15 works · 3 trials
• Hodgkin lymphoma15 works · 0 trials
• Obstructive sleep apnoea14 works · 0 trials
• Diffuse large B-cell lymphoma14 works · 0 trials
• Sickle cell disease14 works · 1 trial
• Long COVID and ME/CFS13 works · 3 trials
• Down syndrome12 works · 0 trials
• Sarcoidosis12 works · 0 trials
• Ventricular tachycardia12 works · 0 trials
• Hidradenitis suppurativa12 works · 0 trials
• Acute lymphoblastic leukaemia12 works · 0 trials
• Childhood cancers11 works · 0 trials
• Myocarditis10 works · 0 trials
• Vitiligo8 works · 0 trials
• Neuroblastoma8 works · 0 trials
• Irritable bowel syndrome8 works · 0 trials
• Meningioma7 works · 0 trials